Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

william-blair-maintains-outperform-on-klaviyo,-inc-(kvyo)-march-2026

William Blair Maintains Outperform on Klaviyo, Inc (KVYO) March 2026

Mar 3, 2026

On March 02, 2026 William Blair maintained Outperform on Klaviyo, Inc. (KVYO) after the company announced a stock…

Read more
raymond-james-downgrades-avav-(aerovironment,-inc.)-to-underperform-march-2026

Raymond James Downgrades AVAV (AeroVironment, Inc.) to Underperform March 2026

Mar 3, 2026

The AVAV analyst rating moved sharply on March 02, 2026 when Raymond James downgraded AeroVironment, Inc. (AVAV) from…

Read more
outperform-maintained-on-asnd-ascendis-pharma-a/s-by-evercore-mar-02,-2026

Outperform Maintained on ASND Ascendis Pharma A/S by Evercore Mar 02, 2026

Mar 3, 2026

Evercore ISI maintained an Outperform rating on Ascendis Pharma A/S (ASND) on March 02, 2026 and raised its…

Read more
ubs-and-craig-hallum-maintain-buy-on-docebo-inc.-(dcbo)-march-2026

UBS and Craig-Hallum Maintain Buy on Docebo Inc. (DCBO) March 2026

Mar 3, 2026

UBS and Craig-Hallum maintained a Buy rating on Docebo Inc. (DCBO) on March 02, 2026. The DCBO analyst…

Read more
goldman-sachs-maintains-buy-on-adt-(adt-inc.)-march-2026

Goldman Sachs Maintains Buy on ADT (ADT Inc.) March 2026

Mar 3, 2026

Goldman Sachs maintained a Buy on ADT (ADT Inc.) on March 02, 2026 after flagging possible negative investor…

Read more
cowen-maintains-hold-on-purecycle-technologies,-inc.-(pct)-march-2026

Cowen Maintains Hold on PureCycle Technologies, Inc. (PCT) March 2026

Mar 3, 2026

On March 2, 2026, Cowen & Co. maintained a Hold on PureCycle Technologies, Inc. (PCT) and lowered its…

Read more
overweight-maintained-for-dyne-therapeutics-(dyn)-by-morgan-stanley-march-2026

Overweight Maintained for Dyne Therapeutics (DYN) by Morgan Stanley March 2026

Mar 3, 2026

Morgan Stanley maintained Overweight on Dyne Therapeutics, Inc. (DYN) on March 02, 2026. This DYN analyst rating came…

Read more
morgan-stanley-maintains-overweight-on-netease,-inc.-(ntes)-mar-2026

Morgan Stanley Maintains Overweight on NetEase, Inc. (NTES) Mar 2026

Mar 3, 2026

Morgan Stanley maintained an Overweight rating on NetEase, Inc. (NTES) on March 02, 2026, signaling continued conviction in…

Read more
evercore-isi-maintains-outperform-on-apple-inc.-(aapl)-march-02,-2026

Evercore ISI Maintains Outperform on Apple Inc. (AAPL) March 02, 2026

Mar 2, 2026

Evercore ISI on March 02, 2026 at 11:30 AM maintained an Outperform rating on Apple Inc. (AAPL), a…

Read more
ubs-maintains-buy-on-sionna-therapeutics,-inc.-(sion)-march-02,-2026

UBS Maintains Buy on Sionna Therapeutics, Inc. (SION) March 02, 2026

Mar 2, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
rbc-capital-downgrades-uniqure-nv.-(qure)-to-sector-perform-mar-2026

RBC Capital Downgrades uniQure N.V. (QURE) to Sector Perform Mar 2026

Mar 2, 2026

RBC Capital downgraded uniQure N.V. (QURE) from Outperform to Sector Perform on March 02, 2026. The move is…

Read more
oppenheimer-maintains-outperform-on-urogen-pharma-ltd.-(urgn)-march-2026

Oppenheimer Maintains Outperform on UroGen Pharma Ltd. (URGN) March 2026

Mar 2, 2026

Oppenheimer maintained an Outperform rating on UroGen Pharma Ltd. (URGN) on March 02, 2026, a clear signal in…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 21
  6. 22
  7. 23
  8. 24
  9. 25
  10. 26
  11. 27
  12. ...
  13. 378
  14. »

Posts pagination

Newer posts Page 1 … Page 24 … Page 378 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.